IN2012DN00486A - - Google Patents

Download PDF

Info

Publication number
IN2012DN00486A
IN2012DN00486A IN486DEN2012A IN2012DN00486A IN 2012DN00486 A IN2012DN00486 A IN 2012DN00486A IN 486DEN2012 A IN486DEN2012 A IN 486DEN2012A IN 2012DN00486 A IN2012DN00486 A IN 2012DN00486A
Authority
IN
India
Prior art keywords
attenuate
exercise
loss
nutritional
functional status
Prior art date
Application number
Other languages
English (en)
Inventor
Kevin Burke Miller
Ingo Arne Jurk
Zamzam Fariba Roughead
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of IN2012DN00486A publication Critical patent/IN2012DN00486A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/19—Dairy proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20—Milk; Whey; Colostrum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
    • A61K36/815—Lycium (desert-thorn)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A61K38/063—Glutathione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44—Oxidoreductases (1)
    • A61K38/446—Superoxide dismutase (1.15)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/06—Anabolic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/08—Mydriatics or cycloplegics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Virology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Inorganic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
IN486DEN2012 2009-07-20 2010-07-15 IN2012DN00486A (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US22680609P 2009-07-20 2009-07-20
US33424710P 2010-05-13 2010-05-13
PCT/US2010/042083 WO2011011252A1 (fr) 2009-07-20 2010-07-15 Procédés d'atténuation de la perte de l'état fonctionnel

Publications (1)

Publication Number Publication Date
IN2012DN00486A true IN2012DN00486A (fr) 2015-05-22

Family

ID=42990259

Family Applications (1)

Application Number Title Priority Date Filing Date
IN486DEN2012 IN2012DN00486A (fr) 2009-07-20 2010-07-15

Country Status (13)

Country Link
US (1) US20120195873A1 (fr)
EP (2) EP3231435A1 (fr)
JP (1) JP2012533627A (fr)
CN (1) CN102647990A (fr)
AU (1) AU2010274125B2 (fr)
BR (1) BR112012001488A2 (fr)
CA (1) CA2768471A1 (fr)
IN (1) IN2012DN00486A (fr)
MX (1) MX2012000943A (fr)
RU (1) RU2012105901A (fr)
SG (1) SG177664A1 (fr)
WO (1) WO2011011252A1 (fr)
ZA (1) ZA201201229B (fr)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TR201811254T4 (tr) * 2010-03-12 2018-08-27 Nestec Sa Lösin tadını maskelemek için bileşimler ve aynısını yapma yöntemleri.
BR112012027427A2 (pt) * 2010-04-26 2015-09-15 Nestec Sa composições nutritivas e métodos para a mudança da nutrição parenteral para a nutrição enteral
WO2012005568A1 (fr) 2010-07-07 2012-01-12 N.V. Nutricia Composition nutritive de stimulation de synthèse de protéines musculaires
WO2012113503A1 (fr) * 2011-02-25 2012-08-30 Merck Patent Gmbh Composition destinée à améliorer la stabilité articulaire et/ou posturale
EP2699110A1 (fr) * 2011-04-18 2014-02-26 Nestec S.A. Compositions nutritionnelles comprenant de l'alpha-hica et de l'alpha-cétoglutarate
RU2013158289A (ru) * 2011-06-08 2015-07-20 Нестек С.А. Питательные композиции, содержащие экзогенные компоненты мембран жировых глобул молока
JP2013051920A (ja) * 2011-09-05 2013-03-21 Ishikawa Prefectural Public Univ Corp 骨密度強化補助食品
EP2580967A1 (fr) * 2011-10-11 2013-04-17 Nestec S.A. Accélération de récupération musculaire après une atrophie du muscle induite par l'immobilisation
EP2583563A1 (fr) * 2011-10-21 2013-04-24 Nestec S.A. Micelles de protéine de lactosérum contre l'amyotrophie et la sarcopénie
EP2583566B1 (fr) * 2011-10-21 2015-08-19 Nestec S.A. Micelles de protéine de lactosérum pour améliorer la masse musculaire et la performance
EP2583565A1 (fr) * 2011-10-21 2013-04-24 Nestec S.A. Utilisation de micelles de protéines de lactosérum pour améliorer la dépense énergétique et la satiété
NZ625685A (en) * 2012-01-03 2016-04-29 Nestec Sa Compositions and methods for the stability of reactive amino acids in a food matrix
RU2520036C2 (ru) * 2012-03-01 2014-06-20 Общество с ограниченной ответственностью "Институт новых технологий" Пищевой продукт "миоактив-спорт" для питания людей, подверженных интенсивным физическим нагрузкам
WO2014055905A1 (fr) 2012-10-04 2014-04-10 Abbott Laboratories Méthodes d'amélioration de l'effet de l'egcg sur l'atténuation de la perte musculaire squelettique
CN103783532B (zh) * 2012-10-29 2016-06-08 杭州纽曲星生物科技有限公司 一种抗老年性肌肉衰减的复合蛋白质粉及其制备方法
CN103271350B (zh) * 2013-03-04 2014-09-24 中国航天员科研训练中心 空间站航天员太空高能压缩食品及其制法
JP2016513701A (ja) * 2013-03-14 2016-05-16 アボット・ラボラトリーズＡｂｂｏｔｔ Ｌａｂｏｒａｔｏｒｉｅｓ 長期身体不活動に関連するインスリン抵抗性の治療
MX2015013000A (es) 2013-03-15 2015-12-01 Abbott Lab Metodos de mantenimiento y mejora de la funcion muscular.
CA2909211C (fr) * 2013-04-15 2021-06-22 Nestec S.A. Utilisation de proteine du petit-lait en combinaison avec une stimulation electrique de muscle
CN105188413A (zh) * 2013-05-01 2015-12-23 雅培公司 增强老化肌肉再生的方法
US20140357576A1 (en) * 2013-05-31 2014-12-04 Nestec S.A. Methods for enhancement of muscle protein synthesis
CN105451578A (zh) 2013-06-10 2016-03-30 N·V·努特里奇亚 超重或肥胖成年人在体重减轻项目期间的肌肉保持
JP6279851B2 (ja) * 2013-07-19 2018-02-14 雪印メグミルク株式会社 筋萎縮防止及び／又は筋合成促進剤
CA2950501C (fr) * 2014-07-21 2022-08-09 Nestec S.A. Produits nutritionnels favorisant une deglutition sure pour des individus atteints de dysphagie
ES2651903T3 (es) * 2014-10-08 2018-01-30 Professional Dietetics S.P.A. Composiciones que comprenden aminoácidos para su uso en el tratamiento del estado inflamatorio sistémico asociado con el accidente cerebrovascular en pacientes con disfagia
US20190111083A1 (en) * 2014-10-14 2019-04-18 Nestec S.A. Improvement in muscle functionality of elderly males
JP2018503599A (ja) * 2014-11-19 2018-02-08 ネステク ソシエテ アノニム 体重を管理するための乳清タンパク質ミセルとペクチンの複合体の使用
EP3851114A1 (fr) * 2015-11-20 2021-07-21 Société des Produits Nestlé S.A. Composition comprenant des protéines lactosériques micellaires pour améliorer ou maintenir les muscles
CN108430490A (zh) * 2015-12-03 2018-08-21 株式会社明治 营养组合物
JP6935403B2 (ja) 2015-12-22 2021-09-15 ソシエテ・デ・プロデュイ・ネスレ・エス・アー サルコペニア及びフレイルの処置方法
TW201808120A (zh) * 2016-03-16 2018-03-16 味之素股份有限公司 行動體力提升劑
JP2019513802A (ja) * 2016-04-14 2019-05-30 ルシー マイケル 組み合わせ組成物およびその使用方法
JP6948103B2 (ja) * 2016-04-14 2021-10-13 株式会社明治 フレイル改善用組み合わせ物
CA3024365A1 (fr) * 2016-05-27 2017-11-30 Nestec S.A. Composition nutritionnelle pour le traitement ou la prevention de la diminution de la mobilite
EP3541206B1 (fr) * 2016-11-16 2020-05-13 Fresenius Kabi Deutschland GmbH Composition nutritionnelle à utiliser dans la thérapie de patients atteints de fragilité et/ou de sarcopénie ou de pré-sarcopénie ou de fragilité précoce
JOP20190146A1 (ar) 2016-12-19 2019-06-18 Axcella Health Inc تركيبات حمض أميني وطرق لمعالجة أمراض الكبد
CA3052324C (fr) 2017-03-03 2020-11-03 Exerkine Corporation Composition a elements nutritifs multiples
WO2018221526A1 (fr) * 2017-06-01 2018-12-06 株式会社明治 Composition nutritionnelle
SG11202001142VA (en) 2017-08-14 2020-03-30 Axcella Health Inc Amino acid compositions for the treatment of liver disease
MA52971A (fr) 2018-06-20 2021-04-28 Axcella Health Inc Compositions et procédés pour le traitement de l'infiltration de graisse dans le muscle
JP7044306B2 (ja) * 2018-07-31 2022-03-30 ユーハ味覚糖株式会社 ロイシン血中濃度上昇促進剤及びその用途
FI3989999T3 (fi) * 2019-06-28 2023-07-24 Dompe Farm Spa Haaraketjuisia aminohappoja käsittävä uusi koostumus

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2683492B2 (ja) * 1993-09-07 1997-11-26 雪印乳業株式会社 ミセル状ホエー蛋白質、その溶液、その粉末およびミセル状ホエー蛋白質の製造法
CN1101810A (zh) * 1994-08-23 1995-04-26 谢宝兴 茯苓枸杞子口服液饮料袋泡茶及其生产方法
EP1062876A1 (fr) * 1999-02-25 2000-12-27 Societe Des Produits Nestle S.A. Caséinoglycomacropeptides comme agent de calcification
US20020044988A1 (en) * 2000-08-22 2002-04-18 Fuchs Eileen C. Nutritional composition and method for improving protein deposition
US7794770B2 (en) * 2004-10-07 2010-09-14 Next Proteins, Inc. Protein beverage and method of making the same
US20060198899A1 (en) * 2005-03-01 2006-09-07 Gardiner Paul T Supplemental dietary composition for supporting muscle growth, recovery and strength
FR2882896B1 (fr) * 2005-03-14 2007-05-04 Larena Sa Composition alimentaire pour prevenir le syndrome de fragilite chez les personnes agees
US20070020358A1 (en) * 2005-03-18 2007-01-25 Mower Thomas E Sports drink concentrate
US20070036873A1 (en) 2005-07-27 2007-02-15 Shibnath Ghosal Method of treatment or management of stress
EP1940426A4 (fr) * 2005-09-09 2009-10-28 Murray Goulburn Coop Co Ltd Composition d'extrait de facteur du petit-lait servant à réduire les inflammations musculaires
PL1839495T3 (pl) * 2006-03-27 2011-07-29 Nestec Sa Mrożone desery wzbogacone w białko
DE602006005609D1 (de) * 2006-03-27 2009-04-23 Nestec Sa Im Produkt generierte Molkenprotein-Micellen
US20100152107A1 (en) * 2006-10-19 2010-06-17 Nestec S.A. Long-term feed - cancer patient
AR060847A1 (es) 2007-05-03 2008-07-16 Spannagel Lucia Antonia Formulacion a base de calendula, aloe y centella.
BRPI0912571A2 (pt) * 2008-05-21 2015-07-28 Stokely Van Camp Inc Bebida de recuperação à base de leite
WO2010002242A1 (fr) * 2008-07-02 2010-01-07 N.V. Nutricia Composition nutritionnelle pour améliorer la fonction musculaire et l'activité quotidienne

Also Published As

Publication number Publication date
AU2010274125B2 (en) 2015-11-05
CA2768471A1 (fr) 2011-01-27
CN102647990A (zh) 2012-08-22
SG177664A1 (en) 2012-02-28
AU2010274125A1 (en) 2012-02-16
EP2456448A1 (fr) 2012-05-30
EP3231435A1 (fr) 2017-10-18
JP2012533627A (ja) 2012-12-27
ZA201201229B (en) 2013-07-31
RU2012105901A (ru) 2013-08-27
US20120195873A1 (en) 2012-08-02
BR112012001488A2 (pt) 2019-10-08
WO2011011252A1 (fr) 2011-01-27
MX2012000943A (es) 2012-02-28

Similar Documents

Publication Publication Date Title
IN2012DN00486A (fr)
ZA201103584B (en) Whey protein compositions,methods and uses
IN2012DN01920A (fr)
IN2015DN03322A (fr)
WO2013122932A3 (fr) Utilisation topique d'un agent prébiotique commensal dermique et compositions le contenant
GEP201706733B (en) Anti-il-23 antibodies
EP2657333A4 (fr) Circovirus porcin de type 2, composition immunitaire contenant celui-ci, kit de dosage et utilisation de celui-ci
ZA201300690B (en) Hypocaloric,high protein nutritional compositions and methods of using same
MX2016008226A (es) Metodos para el cuidado oral prebiotico usando un sacarido.
IN2014CN02970A (fr)
MX2013012136A (es) Composiciones que comprenden un antimetabolito de glucosa y selenio.
WO2011019641A3 (fr) Compositions nutritionnelles comprenant des nucléotides exogènes
MY155615A (en) Nutritional compositions comprising fruit flakes containing docosahexaenoic acid
MX2010008280A (es) Composicion para estimular la actividad de celula asesina natural.
PH12015500049B1 (en) Novel protein material
EP2551272A4 (fr) Intermédiaire de lycopène de type 1,3,6,10-tétraphosphonate de pentadécyle à double liaison, son procédé de préparation et ses applications
BRPI1015300A8 (pt) "composição nutricional compreendendo um extrato de maçã e reduzindo os sintomas de alergia a alimentos, especialmente em crianças"
MX342306B (es) Composicion de chocolate aireada.
WO2011037712A3 (fr) Compositions nutritionnelles comprenant de la théanine et des nucléotides exogènes
WO2012081893A3 (fr) Nouveau dérivé de 3-indolinone et composition le comprenant
PL2535047T3 (pl) Kompozycja odżywcza, suplement diety zawierający kompozycję odżywczą i zestaw zawierający suplement diety
GEP20156373B (en) Use of 3-carboxy-n-ethyl-n,n-dimethylpropan-1-aminium salts in the treatment of cardiovascular disease
WO2012119049A3 (fr) Compositions nutritionnelles comprenant de l'extrait de prune et de la curcumine biodisponible
UA57577U (ru) Композиция бисквитного полуфабриката
GB201006592D0 (en) Improvements in and relating to nutritional compositions